Topical Cidofovir for Treatment-Refractory Ocular Surface Squamous Neoplasia.

Ophthalmology

Faculty of Medicine, University of New South Wales, Sydney, Australia; Department of Ophthalmology, Prince of Wales Hospital, Randwick, Australia.

Published: April 2018

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2017.11.021DOI Listing

Publication Analysis

Top Keywords

topical cidofovir
4
cidofovir treatment-refractory
4
treatment-refractory ocular
4
ocular surface
4
surface squamous
4
squamous neoplasia
4
topical
1
treatment-refractory
1
ocular
1
surface
1

Similar Publications

Innovation in Warts and Molluscum: An Updated Comprehensive Review.

Dermatol Clin

January 2025

Department of Clinical Research, Center for Clinical Studies, LTD, Webster, TX 77598, USA; Department of Dermatology, The University of Texas Health Science Center at Houston, Bellaire, TX 77401, USA.

This comprehensive review article gives an up-to-date assessment of the therapeutic landscape for warts and molluscum contagiosum (MC), focusing on advances made in the last 5 years. New treatment choices include VP-102 (Ycanth) for molluscum contagiosum, potentially intralesional Vitamin D3 for warts, and topical cidofovir for both. Immunotherapy is regarded as a potential option, especially in difficult situations.

View Article and Find Full Text PDF

Management of Refractory/Resistant Herpes Simplex Virus Infections in Haematopoietic Stem Cell Transplantation Recipients: A Literature Review.

Rev Med Virol

September 2024

AP-HP, Centre National de Référence Herpèsvirus (Laboratoire Associé), Hôpital Pitié-Salpêtrière, Service de Virologie, and Sorbonne Université, INSERM, UMR-S 1136, Institut Pierre Louis d'Épidémiologie et de Santé Publique (iPLESP), Paris, France.

Herpes simplex virus (HSV) infections in allogeneic haematopoietic stem cell transplantation (HSCT) recipients pose significant challenges, with higher incidence, severity, and risk of emergence of resistance to antivirals due to impaired T-cell mediated immunity. This literature review focuses on acyclovir-refractory/resistant HSV infections in HSCT recipients. The review addresses the efficacy of antiviral prophylaxis, the incidence of acyclovir-refractory/resistant HSV infections, and the identification of risk factors and potential prognostic impact associated with those infections.

View Article and Find Full Text PDF
Article Synopsis
  • * A systematic review identified 80 relevant studies out of 126 searched, highlighting that the diagnosis of AEV can take an average of 7 years and lesions remain unchanged with standard HIV treatments, making management challenging.
  • * Current treatments for AEV, such as glycolic acid and imiquimod, show limited effectiveness, and while the risk of certain skin cancers is lower in A
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!